Summit Therapeutics Inc. - COM (SMMT)

CUSIP: 86627T108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
9,061,824
Share change
+512,002
Total reported value
$42,589,259
Price per share
$4.70
Number of holders
31
Value change
+$2,512,909
Number of buys
23
Number of sells
7

Security key

86627T108

Report period

Q4 2020

Institutions

31

Top holders

10

Top shareholders of SMMT - Summit Therapeutics Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Polar Capital LLP
13F
Company
class O/S missing
5,000,000
$17,200,000 30 Sep 2020
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
1,565,086
$5,478,000 30 Sep 2020
13F
BAILLIE GIFFORD & CO
13F
Company
class O/S missing
372,261
$1,281,000 30 Sep 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
303,412
$1,044,000 30 Sep 2020
13F
MORGAN STANLEY
13F
Company
class O/S missing
210,051
$723,000 30 Sep 2020
13F
UBS Group AG
13F
Company
class O/S missing
140,960
$485,000 30 Sep 2020
13F
BBR PARTNERS, LLC
13F
Company
class O/S missing
50,000
$172,000 30 Sep 2020
13F
MIRABELLA FINANCIAL SERVICES LLP
13F
Company
class O/S missing
36,380
$125,000 30 Sep 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
35,000
$120,000 30 Sep 2020
13F
HSBC HOLDINGS PLC
13F
Company
class O/S missing
27,342
$94,000 30 Sep 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
19,411
$66,000 30 Sep 2020
13F
HRT FINANCIAL LP
13F
Company
class O/S missing
18,119
$62,000 30 Sep 2020
13F
Inscription Capital, LLC
13F
Company
class O/S missing
17,000
$58,000 30 Sep 2020
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
class O/S missing
11,000
$37,000 30 Sep 2020
13F
Advisory Services Network, LLC
13F
Company
class O/S missing
7,600
$26,000 30 Sep 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
3,000
$10,000 30 Sep 2020
13F
American Portfolios Advisors
13F
Company
class O/S missing
1,000
$3,440 30 Sep 2020
13F
GROUP ONE TRADING LLC
13F
Company
class O/S missing
400
$1,000 30 Sep 2020
13F
CITIGROUP INC
13F
Company
class O/S missing
200
$1,000 30 Sep 2020
13F

Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2020

As of 31 Dec 2020, Summit Therapeutics Inc. - COM (SMMT) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,061,824 shares. The largest 10 holders included Polar Capital Holdings Plc, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, BAILLIE GIFFORD & CO, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, ExodusPoint Capital Management, LP, UBS Group AG, and WELLS FARGO & COMPANY/MN. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
15
Q4 2020 holders
31
Holder diff
16
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .